Concerns About Radiolabelled Liposomal Doxorubicin in Brain Tumours
Author Information
Author(s): Laverman P, Boerman O C, Storm G, Oyen W J G
Primary Institution: University Medical Center Nijmegen
Conclusion
The authors express concerns about the labelling method and imaging protocol used in previous studies on radiolabelled liposomal doxorubicin.
Supporting Evidence
- The labelling method used may yield an unstable product.
- Only 1% of the radiolabelled activity was associated with the liposomes in their analysis.
- Imaging was performed too early, potentially misrepresenting the results.
Takeaway
The way the liposomes were labelled might not work well, and the imaging done too early could lead to misleading results.
Methodology
The authors attempted to reproduce a labelling method and analyzed the labelling mixture using chromatography techniques.
Potential Biases
Potential bias in interpreting the results of the original studies due to the authors' vested interest in alternative methods.
Limitations
The commentary does not provide original experimental data but critiques previous studies.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website